|
__________________________________________________________________________________________
Dr. Khanna is the founder and CEO of DiscoveRx. He has had over 25 years of experience in biotechnology industry and played a key role in the commercialization of the Enzyme Fragment Complementation (EFC) Assay technology. He has over 40 issued patents and approximately 40 scientific publications. He is an inventor on the vast majority of patents related to the use and applications of EFC Assay technology. Prior to founding DiscoveRx, Dr. Khanna was President and CEO of Microgenics, which was founded as a result of a management buy-out from the Roche-Boehringer Mannheim merger. Dr. Khanna has also served as Vice President and Head of the U.S. Laboratory Diagnostics Division for Boehringer Mannheim Corp. He was a cofounder of ChemTrak and Assistant Director of Research for the Syva Company. Dr. Khanna has a Ph.D. in bio-organic chemistry.
back to top
Mr. Mullane has over 23 years of experience in sales, marketing and operations management in companies ranging in size from several million to over a billion dollars in annual revenue. Prior to joining DiscoveRx, Mr. Mullane was President and CEO of Biolog, Inc. a privately held biotechnology company in Northern California where he successfully led the company for the last several years. His earlier career included roles in operations, business development, and sales and marketing management at Boehringer Mannheim Corp., Biotrack, Inc., Ciba Corning Inc., Baxter, and American Hospital Supply Corp. Mr. Mullane has a B.A. degree in Microbiology.
back to to
Ms. Sailaja Kuchibhatla is Senior Vice President of Business Development responsible for activities that include creating and managing new business opportunities and initiatives for the drug discovery research market, and licensing in to DiscoveRx and licensing out DiscoveRx technologies. Ms. Kuchibhatla began her career at Clontech in 1989 in the research and development organization. After six years of varied and increasing responsibility within R&D, she moved into Marketing, followed by her most recent appointment as VP of Business Development. As a key member of the marketing and business development group for the last 10 years, Ms. Kuchibhatla handled various responsibilities, including leading the marketing team and licensing of key technologies for Clontech in the last five years. She was a member of the Senior Leadership team at BD Biosciences/Clontech and a member of the Technology Strategy and a Business Development team at BD Biosciences. She holds MS and BS degrees in Plant Sciences.
back to top
Dr. Keith Olson is responsible for all R&D activities at DiscoveRx. Dr. Olson holds a Ph.D. in Cell & Molecular Biology, and has been involved in the development of cell based assays and technologies for HTS, HCS and basic research applications. He entered the biotechnology industry in 1997 as a senior scientist for Cellomics, Inc., where he went on to hold numerous positions within product development, product management, sales and marketing. He was a key player in the early commercial adoption of High Content Screening in the drug discovery market. In 2003, he joined Guava Technologies as Director of Product Commercialization, and was instrumental in the launch and proliferation of their novel benchtop cytometry systems, as well as associated reagent kits and software modules. Dr. Olson is an author on numerous publications and patents in the field of cell biology, and is a member of a number of professional societies.
back to top
Mr. Jagdish Saini, VP of Operations brings over 24 years of experience in the Biotechnology industry in various Management positions. His roles have included leading positions in Operations, Technical Services and R&D. Prior to joining DiscoveRx, Mr. Saini was Director of Operations of Cortex Biochem, Inc. a privately held biotechnology company in San Leandro. He has worked extensively with Enzyme Fragment Technology and was a key player in the development of CEDIA technology and its application to a wide range of instruments while working at Microgenics Corp. and Roche-Boehringer Mannheim. His earlier careers included working at BioGenex Laboratories, and teaching at DAV College Chandigarh, India. Mr.Saini has a Master’s degree in Chemistry/Biochemistry from Punjabi University, India.
back to top
|
 |
|
About Us
